| First Author | Lam IKY | Year | 2018 |
| Journal | Cancer Lett | Volume | 431 |
| Pages | 201-212 | PubMed ID | 29859876 |
| Mgi Jnum | J:263929 | Mgi Id | MGI:6187771 |
| Doi | 10.1016/j.canlet.2018.05.044 | Citation | Lam IKY, et al. (2018) MicroRNA-mediated immune regulation in rheumatic diseases. Cancer Lett 431:201-212 |
| abstractText | MicroRNAs (miRNAs) are endogenous small, non-coding RNAs that regulate genome expression at the post-transcriptional level. They are involved in a wide range of physiological processes including the maintenance of immune homeostasis and normal function. Accumulating evidence from animal studies show that alterations in pan or specific miRNA expression would break immunological tolerance, leading to autoimmunity. Differential miRNA expressions have also been documented in patients of many autoimmune disorders. In this review, we highlight the evidence that signifies the critical role of miRNAs in autoimmunity, specifically on their regulatory roles in the pathogenesis of several rheumatic diseases including systemic lupus erythematosus, rheumatoid arthritis and spondyloarthritis. The potential of miRNAs as biomarkers and therapeutic targets is also discussed. Manipulation of dysregulated miRNAs in vivo through miRNA delivery or inhibition offers promise for new therapeutic strategies in treating rheumatic diseases. |
